Motusol Rx (Diclofenac Diethylamine)

Diclofenac, the active ingredient in Motusol Rx, is a nonsteroidal anti‑inflammatory drug presented as a topical formulation for local use. It treats musculoskeletal pain, inflammatory conditions, sprains and strains in adults.

GNH USA supplies Motusol Rx as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Diclofenac topical is used to manage pain and inflammation in the musculoskeletal system and related soft‑tissue injuries.

Musculoskeletal pain: Reduces pain and inflammation in joints and muscles. Inflammatory conditions: Alleviates swelling and discomfort in localized inflammatory sites. Sprains and strains: Provides symptomatic relief and supports faster functional recovery.

Topical diclofenac may cause skin‑related reactions and, rarely, systemic adverse events.

Common Side Effects: - Skin irritation or burning at the application site - Itching or pruritus - Dryness or peeling of the skin - Redness (erythema) or mild rash

Serious or Rare Side Effects: - Severe allergic reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis - Systemic NSAID effects including gastrointestinal ulceration or bleeding - Renal or hepatic impairment in susceptible individuals

Before using Motusol Rx, consider the following safety measures.

Avoid use on broken skin: Do not apply to open wounds or infected areas. Limit application area: Do not exceed the prescribed surface area or frequency. Concurrent NSAID use: Discuss with a prescriber to avoid additive systemic exposure. Pregnancy and lactation: Use only if the potential benefit outweighs the risk. Medical conditions: Exercise caution in patients with cardiovascular, renal or hepatic disease. Store at ambient temperature: Keep below 25 °C, in the original packaging, protected from moisture and light.

Diclofenac topical can interact with systemic medications; monitor the following.

Major Interactions (Avoid): - Concurrent systemic NSAIDs: Heightened risk of gastrointestinal bleeding. - Anticoagulants (e.g., warfarin): Potential enhancement of anticoagulant effect. - Lithium: May increase serum lithium concentrations.

Moderate Interactions (Monitor Closely): - Diuretics: Possible reduction in renal clearance of diclofenac. - ACE inhibitors or ARBs: May impair renal function when combined. - Methotrexate: Risk of increased methotrexate toxicity.